Veradermics, Incorporated
NYSEMANE short interest plummets 39.6% in one week to 3.9M shares as cost to borrow drops 44.5%.
Veradermics heads into the week with a striking divergence: the analyst community is loudly bullish, while short sellers have been quietly adding exposure. The Street's conviction on MANE has rarely looked this…
MANE heads into this week's key catalyst event with short sellers piling back in at the fastest pace in months — even as the stock has nearly doubled since April. The short interest story here is one of conviction…
Snapshot as of 18 Aug 2026
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MANE — free to start on ORTEX.
Sign up for free →Open MANE on ORTEX